Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin and Nadroparin in Acute Ischemic Stroke
NCT01862978Phase 4Unknown
- Sponsor
- University Hospital Martin
- Start
- May 2013
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ischemic stroke comparing Heparin, Nadroparin and Placebo (3 arms). Primary endpoints: Safety of nadroparine or heparin at 90 days and Efficacy of nadroparine or heparin at 90 days. Status: unknown.
02
Drugs
heparinnadroparin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01862978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01862978.